Nowak J Z
Pol J Pharmacol Pharm. 1980 Jul-Aug;32(4):451-61.
The action of histamine H1-receptor antagonists: chloropyramine (CIPYR), diphenhydramine (DPHA) and mepyramine (MEP), and histamine H2-receptor antagonist: burimamide (BUR), metiamide (MET) and cimetidine (CIM) and their methylated analogues methylburimamide (MeBUR) and thiaburimamide (ThBUR) on brain monoamines dopamine (DA), noradrenaline (NA) and serotonin (5HT) in the rat was investigated. H1-receptor antagonists CIPYR and DPHA did not significantly influence both DA disappearance after kappa-methyl-p-tyrosine and DOPAC levels in the rat striatum. DPHA had no significant effect on the striatal DA content while CIPYR decreased it. All of the tested H1-receptor antagonists increased both NA and 5HT levels and decreased 5-HIAA concentrations in the hypothalamus and the striatum. Large doses of H2-receptor antagonists (50-259 micrograms ivt) decreased hypothalamic NA content. One nanogram of BUR, MET and ThBUR in NA levels, while such low doses of MeBUR nd CIM did not affect the amine content in the rat hypothalamus, neither acute nor chronic treatment with CIN ip significantly influenced NA,DA and 5HT levels in the brain.
研究了组胺H1受体拮抗剂:氯吡那敏(CIPYR)、苯海拉明(DPHA)和甲氧苄胺嘧啶(MEP),以及组胺H2受体拮抗剂:布立马胺(BUR)、甲硫咪胺(MET)和西咪替丁(CIM)及其甲基化类似物甲基布立马胺(MeBUR)和硫布立马胺(ThBUR)对大鼠脑单胺多巴胺(DA)、去甲肾上腺素(NA)和5-羟色胺(5HT)的作用。H1受体拮抗剂CIPYR和DPHA对大鼠纹状体中κ-甲基-p-酪氨酸后DA消失和DOPAC水平均无显著影响。DPHA对纹状体DA含量无显著影响,而CIPYR使其降低。所有测试的H1受体拮抗剂均增加了下丘脑和纹状体中NA和5HT水平,并降低了5-羟吲哚乙酸(5-HIAA)浓度。大剂量的H2受体拮抗剂(50-259微克静脉注射)降低了下丘脑NA含量。1纳克BUR、MET和ThBUR可降低NA水平,而如此低剂量的MeBUR和CIM对大鼠下丘脑胺含量无影响,腹腔注射CIN急性或慢性治疗均未显著影响脑中NA、DA和5HT水平。